Focus Areas
Food & Drug Law

Food & Drug Law examines the development of effective food and drug laws. The scope of our research includes food, drugs, biologics, and tobacco.

Featured Project

Center of Excellence in Regulatory Science and Innovation (CERSI)

The Georgetown University Center of Excellence in Regulatory Science and Innovation (Georgetown CERSI) is a joint effort between the University and the U.S. Food and Drug Administration (FDA) to work collaboratively on projects that promote regulatory science, including innovative research, education, and scientific exchange. The O’Neill Institute is exploring how open innovation, effective collaboration, and pooling resources will accelerate the business of developing medical products as well as benefitting public health. Although there are numerous benefits, there also exist potential legal and societal barriers — both real and perceived — to the sharing of information. The O’Neill Institute is examining these barriers to data sharing.

The O’Neill Institute for National and Global Health Law at Georgetown University was established in 2007 through the generous philanthropy of Linda and Timothy O’Neill to respond to the need for innovative solutions to the most pressing national and international health concerns. Housed at Georgetown University Law Center in Washington D.C., the O’Neill Institute reflects the importance of public and private law in health policy analysis. The O’Neill Institute draws upon the University's considerable intellectual resources, including the School of Nursing & Health Studies, School of Medicine, the Public Policy Institute, and the Kennedy Institute of Ethics.